SS
EW icon

Steve Schonfeld’s Edwards Lifesciences EW Stock Holding History

Steve Schonfeld’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,000
Closed -$4.71M – 2654
2022
Q1 		$4.71M Buy
+40,000
New +$4.49M 0.04% 465
2021
Q4 		– Sell
-20,000
Closed -$2.26M – 2253
2021
Q3 		$2.26M Buy
+20,000
New +$2.28M 0.02% 677

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Steve Schonfeld's EW Position: Q2 2026 in Review

Steve Schonfeld increased its Edwards Lifesciences (EW) stake by 5,431% in Q2 2026, buying an estimated $15.5M and bringing the position to 188,660 shares worth $17.1M. The position accounts for 0.06% of the portfolio, ranked #282.

Steve Schonfeld first reported a position in EW in Q1 2016 and has held it in 30 quarters since. The position peaked at $33.4M in Q1 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Steve Schonfeld held 188,660 shares of Edwards Lifesciences worth $17.1M as of Q2 2026.
  • Steve Schonfeld bought 185,249 Edwards Lifesciences shares in Q2 2026, an estimated $15.5M.
  • Edwards Lifesciences made up 0.06% of Steve Schonfeld's portfolio in Q2 2026, its #282 holding.
  • Steve Schonfeld first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 30 quarters since.
  • Steve Schonfeld's Edwards Lifesciences position peaked at $33.4M in Q1 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.